Pharmacokinetic study of KRP-116D

KRP-116D Phase I Clinical Pharmacology Study -Pharmacokinetic study of KRP-116D in healthy subjects-

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080223886

Enrollment

Registered

2018-04-24

Start date

2018-05-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

investigational material(s) Generic name etc : KRP-116D INN of investigational material : dimethylsulfoxide Therapeutic category code : 259 Other agents for uro-genital and anal organ Dosage and Admin

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Japanese healthy males BMI more than or equal to 18.5kg/mm and less than 25.0kg/mm etc

Exclusion criteria

Exclusion criteria: Have more than one of the following which is considered inappropriate by the investigator; current disease, medical history or operation in the past. Judged inadequate to participate in the study,etc.

Design outcomes

Primary

Measure	Time frame
pharmacokinetics Pharmacokinetics Drug concentration in plasma and pharmacokinetic parameters	—

Secondary

Measure	Time frame
safety Safety, etc. Adverse events, etc.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026